Phathom Pharmaceuticals(PHAT),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

PHAT Phathom Pharmaceuticals

Market Closed 04-17 16:00:00 EDT

13.19

+0.58

+4.60%

盘后13.15

-0.04-0.32%

17:48 EDT

High13.27	Low12.67	Vol922.62K
Open12.88	D1 Closing12.61	Amplitude4.80%
Mkt Cap1.05B	Tradable Cap759.31M	Total Shares79.43M
T/O12.06M	T/O Rate1.60%	Tradable Shares57.57M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"PHAT","market":"US","secType":"STK","nameCN":"Phathom Pharmaceuticals","latestPrice":13.19,"timestamp":1776456000000,"preClose":12.61,"halted":0,"volume":922615,"hourTrading":{"tag":"盘后","latestPrice":13.147266,"preClose":13.19,"latestTime":"17:48 EDT","volume":18508,"amount":244034.368034,"timestamp":1776462488922,"change":-0.042734,"changeRate":-0.00324,"amplitude":0.00324},"delay":0,"changeRate":0.04599524187153054,"floatShares":57566899,"shares":79430117,"eps":-3.034157,"marketStatus":"Market Closed","change":0.58,"latestTime":"04-17 16:00:00 EDT","open":12.88,"high":13.27,"low":12.665,"amount":12061541.48938,"amplitude":0.047978,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.034157,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1776672000000},"marketStatusCode":7,"adr":0,"listingDate":1571976000000,"exchange":"NASDAQ","adjPreClose":12.61,"preHourTrading":{"tag":"盘前","latestPrice":12.87,"preClose":12.61,"latestTime":"09:29 EDT","volume":7311,"amount":93300.993408,"timestamp":1776432599999,"change":0.26,"changeRate":0.020619,"amplitude":0.020619},"postHourTrading":{"tag":"盘后","latestPrice":13.147266,"preClose":13.19,"latestTime":"17:48 EDT","volume":18508,"amount":244034.368034,"timestamp":1776462488922,"change":-0.042734,"changeRate":-0.00324,"amplitude":0.00324},"volumeRatio":0.9668481193580271,"impliedVol":0.8832,"impliedVolPercentile":0.316},"requestUrl":"/m/hq/s/PHAT","defaultTab":"news","newsList":[{"id":"2627700254","title":"A Look At Phathom Pharmaceuticals (PHAT) Valuation After Recent Stock Momentum Shift","url":"https://stock-news.laohu8.com/highlight/detail?id=2627700254","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627700254?lang=en_us&edition=fundamental","pubTime":"2026-04-15 11:12","pubTimestamp":1776222732,"startTime":"0","endTime":"0","summary":"Stock move puts Phathom Pharmaceuticals in focus\nRecent trading in Phathom Pharmaceuticals (PHAT) has drawn fresh attention to the gastrointestinal drug developer, with investors weighing its current market value against the ongoing commercialization of VOQUEZNA therapies in the United States.\nSee our latest analysis for Phathom Pharmaceuticals.\nAt a share price of $12.67, recent trading has come after a 22.18% 1 month share price return but follows a 19.35% decline year to date and a 165.62%...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-phat/phathom-pharmaceuticals/news/a-look-at-phathom-pharmaceuticals-phat-valuation-after-recen","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-phat/phathom-pharmaceuticals/news/a-look-at-phathom-pharmaceuticals-phat-valuation-after-recen","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4007","PHAT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625305159","title":"Phathom Pharmaceuticals announces annual shareholder meeting via webcast","url":"https://stock-news.laohu8.com/highlight/detail?id=2625305159","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625305159?lang=en_us&edition=fundamental","pubTime":"2026-04-07 20:01","pubTimestamp":1775563293,"startTime":"0","endTime":"0","summary":"Phathom Pharmaceuticals scheduled annual shareholder meeting to be held virtually on May 19, 2026.Shareholders will vote on election of three Class I directors for terms expiring at 2029 annual meeting.Meeting agenda also includes advisory vote on compensation of named executive officers.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Phathom Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 07, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260407:nNDL6ns2C5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PHAT","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625767972","title":"Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2625767972","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625767972?lang=en_us&edition=fundamental","pubTime":"2026-04-06 20:00","pubTimestamp":1775476800,"startTime":"0","endTime":"0","summary":"FLORHAM PARK, N.J., April  06, 2026 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on commercializing and developing novel treatments for gastroi","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/06/3268398/0/en/Phathom-Pharmaceuticals-to-Participate-in-Upcoming-Investor-Conferences.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","PHAT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622876306","title":"BUZZ-U.S. STOCKS ON THE MOVE-Entergy, IDEX Corp, Quanta Services","url":"https://stock-news.laohu8.com/highlight/detail?id=2622876306","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622876306?lang=en_us&edition=fundamental","pubTime":"2026-03-27 23:48","pubTimestamp":1774626488,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Entergy, IDEX Corp, Quanta Services Workspace search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsl","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260327:nL6N40F0XI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FIAT","FCHL","PH","CONX","ETR","AME","ETN","LTRN","FTNT","SAIL","VATE","02026","ICOI","ITRMF","CRWD","CONI","DIS","DISO","EMR","WIX","DOV","ITRM","FPS","PHAT","SHPH","GGLL","ARTL","CCL.UK","AGX","PANW","DDOG","PWR","SST","ZBIO","HKIT","ANAB","TWO","BTGO","CCL","RCKT","HON","IEX","ADMA","GGLS","BKSY","DTCX","VOR"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2622082150","title":"Phathom Pharmaceuticals Raised to Overweight From Equal-Weight by Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2622082150","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622082150?lang=en_us&edition=fundamental","pubTime":"2026-03-27 20:43","pubTimestamp":1774615380,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/PHAT/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 27, 2026 08:43 ET (12:43 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PHAT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622823458","title":"BUZZ- Barclays raises Phathom Pharmaceuticals to 'overweight'; shares rise","url":"https://stock-news.laohu8.com/highlight/detail?id=2622823458","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622823458?lang=en_us&edition=fundamental","pubTime":"2026-03-27 19:12","pubTimestamp":1774609939,"startTime":"0","endTime":"0","summary":"BUZZ- Barclays raises Phathom Pharmaceuticals to 'overweight'; shares rise** Gastrointestinal  diseases-focused biopharma Phathom Pharmaceuticals PHAT.O shares rise 2% to $11 premarket** Barclays upgrades stock to \"overweight\" from \"equal-weight\"** Brokerage raises target price to $18 from $16, which represents 66.8% upside from the stock's last close     ** \"We think the combination of a strengthened balance sheet, strong guidance and focused commercial strategy suggests the stock at ~$11 is dislocated from the fundamentals\" - Barclays** Brokerage notes that more targeted GI approach appears positioned to drive better adoption** As of last close, stock has fallen 34.9% YTD  ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260327:nL4N40F0RA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","PHAT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622840221","title":"Phathom Pharmaceuticals Inc. : Barclays Raises Target Price to $18 From $16","url":"https://stock-news.laohu8.com/highlight/detail?id=2622840221","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622840221?lang=en_us&edition=fundamental","pubTime":"2026-03-27 18:32","pubTimestamp":1774607567,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260327:nAZN4SNK6E:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PHAT","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622841434","title":"Phathom Pharmaceuticals upgraded to Overweight from Equal Weight at Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2622841434","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622841434?lang=en_us&edition=fundamental","pubTime":"2026-03-27 17:00","pubTimestamp":1774602023,"startTime":"0","endTime":"0","summary":"Barclays analyst Jenna Davidner upgraded Phathom Pharmaceuticals (PHAT) to Overweight from Equal Weight with a price target of $18, up from $16. Th...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/phathom-pharmaceuticals-upgraded-to-overweight-from-equal-weight-at-barclays-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/phathom-pharmaceuticals-upgraded-to-overweight-from-equal-weight-at-barclays-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PHAT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622845792","title":"U.S. RESEARCH ROUNDUP- Brown-Forman, Chord Energy, Olaplex Holdings","url":"https://stock-news.laohu8.com/highlight/detail?id=2622845792","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622845792?lang=en_us&edition=fundamental","pubTime":"2026-03-27 15:54","pubTimestamp":1774598066,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP- Brown-Forman, Chord Energy, Olaplex HoldingsMarch 27 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, includ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260327:nL4N40F0FX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PL","LBRX","IE00BMPRXQ63.HKD","PRMB","BK4551","CHRD","GOOX","GGLS","GOOY","BK4134","SPXC","DIS","GGLL","KOD","DISO","PHAT","ATAI","LU0345769128.USD","PLU","MGTX","HAL","OXY","BIOA","OLPX","UNX","LU1815333072.USD","OXM","BK4561","CTAS","NHI","FISV","GNRC","COP","CCL","CMC","FOXA","IT","EOG","GOOP","MASI","BALY","U","AGX","BTGO","GOOW","GOU","KYIV","GOOGL","IMMX","ADP"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2621086501","title":"Phathom Pharmaceuticals management to meet with Cantor","url":"https://stock-news.laohu8.com/highlight/detail?id=2621086501","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621086501?lang=en_us&edition=fundamental","pubTime":"2026-03-24 02:25","pubTimestamp":1774290338,"startTime":"0","endTime":"0","summary":"Meeting to be held in London on March 23, Stockholm March 24 and Zurich March 25 hosted by Cantor. Published first on TheFly – the ultimate source ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/phathom-pharmaceuticals-management-to-meet-with-cantor-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/phathom-pharmaceuticals-management-to-meet-with-cantor-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PHAT","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617598120","title":"Phathom Pharmaceuticals Charts Profitable Path After Ramp-Up","url":"https://stock-news.laohu8.com/highlight/detail?id=2617598120","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617598120?lang=en_us&edition=fundamental","pubTime":"2026-03-05 08:18","pubTimestamp":1772669885,"startTime":"0","endTime":"0","summary":"Phathom Pharmaceuticals, Inc. (($PHAT)) has held its Q4 earnings call. Read on for the main highlights of the call. Phathom Pharmaceuticals’ latest...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/phathom-pharmaceuticals-charts-profitable-path-after-ramp-up?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/phathom-pharmaceuticals-charts-profitable-path-after-ramp-up?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","PHAT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614286857","title":"Phathom Pharmaceuticals Is Maintained at Buy by Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2614286857","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614286857?lang=en_us&edition=fundamental","pubTime":"2026-02-27 23:58","pubTimestamp":1772207880,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/PHAT/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 27, 2026 10:58 ET (15:58 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PHAT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614787853","title":"Phathom Pharmaceuticals price target raised to $25 from $20 at Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2614787853","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614787853?lang=en_us&edition=fundamental","pubTime":"2026-02-27 20:39","pubTimestamp":1772195953,"startTime":"0","endTime":"0","summary":"Guggenheim raised the firm’s price target on Phathom Pharmaceuticals (PHAT) to $25 from $20 and keeps a Buy rating on the shares. The firm, which c...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/phathom-pharmaceuticals-price-target-raised-to-25-from-20-at-guggenheim-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/phathom-pharmaceuticals-price-target-raised-to-25-from-20-at-guggenheim-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PHAT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614085880","title":"Phathom Pharmaceuticals: Early VOQUEZNA Traction, Strengthened Balance Sheet, and Clear Path to Profitability Support Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2614085880","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614085880?lang=en_us&edition=fundamental","pubTime":"2026-02-27 19:55","pubTimestamp":1772193330,"startTime":"0","endTime":"0","summary":"Matthew Caufield, an analyst from H.C. Wainwright, reiterated the Buy rating on Phathom Pharmaceuticals. The associated price target remains the sa...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/phathom-pharmaceuticals-early-voquezna-traction-strengthened-balance-sheet-and-clear-path-to-profitability-support-buy-rating-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/phathom-pharmaceuticals-early-voquezna-traction-strengthened-balance-sheet-and-clear-path-to-profitability-support-buy-rating-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PHAT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614078925","title":"Analysts’ Top Healthcare Picks: Phathom Pharmaceuticals (PHAT), Certara (CERT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2614078925","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614078925?lang=en_us&edition=fundamental","pubTime":"2026-02-27 03:20","pubTimestamp":1772133610,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Phathom Pharmaceuticals (PHAT – Research Report) and...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-phathom-pharmaceuticals-phat-certara-cert-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-phathom-pharmaceuticals-phat-certara-cert-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PHAT","BK4588","XLV","BK4007","HCSG","LU0029874061.USD","BK4585","BK4581","LABU","BK4167","CERT","XBI","LU0128526141.USD","BK4137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614021397","title":"Analysts Have Conflicting Sentiments on These Healthcare Companies: Phathom Pharmaceuticals (PHAT), BioLife Solutions (BLFS) and RxSight (RXST)","url":"https://stock-news.laohu8.com/highlight/detail?id=2614021397","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614021397?lang=en_us&edition=fundamental","pubTime":"2026-02-27 00:20","pubTimestamp":1772122811,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Phathom Pharmaceuticals (PHAT – Research Report), ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-phathom-pharmaceuticals-phat-biolife-solutions-blfs-and-rxsight-rxst-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-phathom-pharmaceuticals-phat-biolife-solutions-blfs-and-rxsight-rxst-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0029874061.USD","BK4198","BK4585","XBI","LU1169590202.USD","BK4137","LU0128526141.USD","BK4007","HCSG","LABU","XLV","BK4539","BK4588","BK4581","RXST","BK4121","PHAT","LU1169589451.USD","BLFS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614879049","title":"Phathom Pharmaceuticals Q4 revenue slightly beats expectations","url":"https://stock-news.laohu8.com/highlight/detail?id=2614879049","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614879049?lang=en_us&edition=fundamental","pubTime":"2026-02-26 20:25","pubTimestamp":1772108749,"startTime":"0","endTime":"0","summary":"Phathom Pharmaceuticals Q4 revenue slightly beats expectationsOverviewBiopharmaceutical firm's Q4 revenue slightly beat analyst expectationsCompany reduced Q4 net loss compared to previous yearStrengt","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260226:nL1N3ZM0LR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","PHAT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614504528","title":"Phathom posts FY 2025 net revenues of USD 175.1 million, up 217%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614504528","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614504528?lang=en_us&edition=fundamental","pubTime":"2026-02-26 20:03","pubTimestamp":1772107429,"startTime":"0","endTime":"0","summary":"Phathom posts FY 2025 net revenues of USD 175.1 million, up 217%               Phathom reported Q4 2025 net revenues of USD 57.6 million and FY 2025 net revenues of USD 175.1 million (up 217% YoY). Q4","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260226:nNDL6b0fYP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","IE00B64PRP62.GBP","SG9999014039.USD","BK4588","BK4112","SG9999014005.SGD","PHAT","IE00B3QW5Z07.USD","LU2095319765.USD","BK4007","SG9999014013.SGD","LU2210150020.SGD","LU2210149790.SGD","SG9999014021.USD","IE00BKPKM429.USD","NDAQ","BK4585","LU0314104364.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614804591","title":"Phathom Pharmaceuticals Q4 Adj. EPS $(0.08) Beats $(0.38) Estimate, Sales $57.584M Beat $57.050M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2614804591","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614804591?lang=en_us&edition=fundamental","pubTime":"2026-02-26 20:01","pubTimestamp":1772107291,"startTime":"0","endTime":"0","summary":"Phathom Pharmaceuticals (NASDAQ:PHAT) reported quarterly losses of $(0.08) per share which beat the analyst consensus estimate of $(0.38) by 79 percent. This is a 89.87 percent increase over losses of $(0.79) per share","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/02/50881899/phathom-pharmaceuticals-q4-adj-eps-0-08-beats-0-38-estimate-sales-57-584m-beat-57-050m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PHAT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614045451","title":"BRIEF-Phathom Pharmaceuticals Q4 Net Income USD -21.148 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2614045451","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614045451?lang=en_us&edition=fundamental","pubTime":"2026-02-26 20:00","pubTimestamp":1772107251,"startTime":"0","endTime":"0","summary":"BRIEF-Phathom Pharmaceuticals Q4 Net Income USD -21.148 Million\n\n\nFeb 26 (Reuters) - Phathom Pharmaceuticals Q4 revenue USD 57.584 million vs. IBES estimate USD 57 million.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260226:nPLX681997:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","PHAT"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.phathompharma.com","stockEarnings":[{"period":"1week","weight":0.0443},{"period":"1month","weight":0.2035},{"period":"3month","weight":-0.0619},{"period":"6month","weight":0.0177},{"period":"1year","weight":2.273},{"period":"ytd","weight":-0.2049}],"compareEarnings":[{"period":"1week","weight":0.0452},{"period":"1month","weight":0.0736},{"period":"3month","weight":0.0267},{"period":"6month","weight":0.0689},{"period":"1year","weight":0.349},{"period":"ytd","weight":0.0414}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Phathom Pharmaceuticals, Inc., biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada for an investigational potassium-competitive acid blocker (P-CAB) that blocks acid secretion in the stomach. It is also developing vonoprazan for the treatment of erosive gastroesophageal reflux disease; and in combination with antibiotics for the treatment of Helicobacter pylori infection. Phathom Pharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Florham Park, New Jersey.","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":-0.079508},{"month":2,"riseRate":0.571429,"avgChangeRate":0.0658},{"month":3,"riseRate":0.142857,"avgChangeRate":-0.119249},{"month":4,"riseRate":0.571429,"avgChangeRate":0.072465},{"month":5,"riseRate":0.5,"avgChangeRate":-0.02431},{"month":6,"riseRate":0.666667,"avgChangeRate":0.246775},{"month":7,"riseRate":0.666667,"avgChangeRate":0.025067},{"month":8,"riseRate":0.666667,"avgChangeRate":0.15186},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.003613},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.040055},{"month":11,"riseRate":0.428571,"avgChangeRate":-0.100392},{"month":12,"riseRate":0.714286,"avgChangeRate":0.070942}],"exchange":"NASDAQ","name":"Phathom Pharmaceuticals","nameEN":"Phathom Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Phathom Pharmaceuticals(PHAT),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Phathom Pharmaceuticals(PHAT) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Phathom Pharmaceuticals,PHAT,Phathom Pharmaceuticals股票,Phathom Pharmaceuticals股票老虎,Phathom Pharmaceuticals股票老虎国际,Phathom Pharmaceuticals行情,Phathom Pharmaceuticals股票行情,Phathom Pharmaceuticals股价,Phathom Pharmaceuticals股市,Phathom Pharmaceuticals股票价格,Phathom Pharmaceuticals股票交易,Phathom Pharmaceuticals股票购买,Phathom Pharmaceuticals股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Phathom Pharmaceuticals(PHAT),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Phathom Pharmaceuticals(PHAT) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}